-
My Account
My Account
61.85 (1.29%) 68.25 (1.43%) 
3.08 pm | 23 Dec 2010 | Source: CNBC-TV18
Dr Reddys Labs is expected to grow at rate of around 26-27% in next 2-3 years. ROEs on capital employed would be around 22-23% and its fairly valued a...
3.05 pm | 23 Dec 2010 | Source: CNBC-TV18
As long as supports close to Rs 1575-1550 holds, Dr Reddys Labs is very likely to bounce back. Whether it takes out Rs 1800-1775 need to see. If one h...
5.16 pm | 22 Dec 2010 | Source: CNBC-TV18
Dr Reddy Labs certainly had a very tragic event. It should have a fairly significant downside impact on the stock, says Radhika Gupta of Forefront Cap...
12.58 pm | 22 Dec 2010 | Source: Reuters
Dr Reddy's Laboratories said on Wednesday authorities were investigating the deaths of an employee and a contractor working at its drug-making unit in...
8.34 pm | 21 Dec 2010 | Source: Reuters
Dr. Reddy's Laboratories said on Tuesday it has signed an agreement with Russia's R-Pharm for licensing, technology transfer, manufacturing and market...
10.05 am | 20 Dec 2010 | Source: CNBC-TV18
Hold Dr Reddys Laboratories, says Anu Jain, Vice President, IIFL Private Wealth Management....
3.13 pm | 10 Dec 2010 | Source: Moneycontrol.com
The National Pharmaceutical Pricing Authority (NPPA) has asked pharmaceutical companies to pay Rs 2,000 crore for overpricing drugs, reports CNBC-TV18...
5.51 pm | 03 Dec 2010 | Source: CNBC-TV18
Mitesh Thacker, Technical Analyst, miteshthacker.com is bullish on IT, pharma sector....
8.33 am | 24 Nov 2010 | Source: Reuters
GlaxoSmithKline is getting out of the oral penicillin business in the United States, selling a factory and two key brands to India's Dr. Reddy's Labor...
7.00 pm | 18 Nov 2010 | Source: CNBC-TV18
Prashastha Seth, Senior VP, IIFL Private Wealth is bullish on Dr Reddys Labs and Sun Pharma....
5.58 pm | 11 Nov 2010 | Source: CNBC-TV18
Dr Reddys Labs may do well in medium to long term perspective, says Dipan Mehta, Member of BSE & NSE....
1.00 pm | 11 Nov 2010 | Source: CNBC-TV18
Sandeep Bhatia of Kotak Institutional Equities remains overweight on banking and auto stocks....
1.36 pm | 30 Oct 2010 | Source: Moneycontrol.com
Emkay Global Financial Services is bullish on Dr Reddys Labs and has recommended accumulate rating on the stock with a target of Rs 1763 in its Octobe...
1.24 pm | 30 Oct 2010 | Source: Moneycontrol.com
Karvy Stock Broking has given a market performer rating on Dr Reddys Laboratories with a target of Rs 1702 in its October 25, 2010 research report....
7.24 pm | 29 Oct 2010 | Source: Moneycontrol.com
KRChoksey has recommended hold rating on Dr Reddys Labs with a target of Rs 1786 in its October 26, 2010 research report....
6.38 pm | 29 Oct 2010 | Source: Moneycontrol.com
Motilal Oswal is bullish on Dr Reddys Labs and has recommended buy rating on the stock with a target of Rs 1680 in its October 22, 2010 research repor...
7.18 pm | 26 Oct 2010 | Source: Moneycontrol.com
PINC Research has recommended hold rating on Dr Reddys Labs with a target of Rs 1554 in its October 25, 2010 research report....
7.13 pm | 26 Oct 2010 | Source: Moneycontrol.com
Dr Reddys Laboratories has reported a sales turnover of Rs 1,296.88 crore and a net profit of Rs 220.20 crore for the quarter ended Sep 2010...
11.40 am | 25 Oct 2010 | Source: CNBC-TV18
Dr Reddy's Laboratories has reports a 11.68% growth in its net profit for the second quarter of fiscal year 2011. The growth in India has been better ...
1.32 pm | 23 Oct 2010 | Source: Moneycontrol.com
Pharma major Dr Reddy's Laboratories has announced its second quarter results of FY11. It has reported net profit at Rs 220 crore as against Rs 197 cr...
